Growth Momentum Positive Development is accelerating growth, evidenced by board additions in 2026 and a total funding runway of about 52M, including a 51.5M round in 2025. The company employs 201-500 people and is headquartered in Tysons, VA, signaling capacity for larger partnerships. Sales opportunities include pursuing payer-driven care models with health plans and hospital systems, and proposing pilots to insurers and integrated care platforms to scale autism and neurodiversity services.

Payer & Partners Strategic investor and funding history includes involvement from CareFirst/Blue Cross Blue Shield-like payer networks, suggesting established payer interest. There is potential to formalize contracts with insurers to expand affordable autism care and to explore co-development opportunities with care management organizations. Action: map senior leaders at major payers and health plans for pilots and value-based care arrangements.

Tech Enablement The tech stack shows readiness for digital engagement and multilingual reach, with tools like Mailgun, Weglot, Cloudflare Bot Management, and HSTS. This enables scalable patient communications, multilingual accessibility, and secure online care workflows. Opportunities exist to offer HIPAA-compliant telehealth, enhanced patient engagement, and EHR integrations as services to expand access.

Market Focus The core focus on neurodivergent children and teens creates a defensible niche with high demand in pediatrics, schools, and community clinics. Partnerships with educational institutions and pediatric practices can accelerate adoption of an affordable, scalable autism care model. Consider co-marketing with pediatric special education networks and hospital outpatient programs.

Expansion Readiness Headquartered in Tysons, VA with growth-ready leadership and funding, the company is positioned for phased geographic expansion and national telehealth delivery. A revenue trajectory in the mid-range and mid-market scale makes it attractive to strategic vendors in care coordination, patient engagement, and payer tech. Next steps include pilot programs with regional insurers and healthcare networks to prove ROI.